Respiration Physiology 114 (1998) 153 – 160 Effect of Fenoterol on PAF-induced lung edema in isolated and perfused rabbit lungs Liuska Pesce, Sandra Tristano, Eliot Friedman, Alejandro Comellas, He ´ctor Marcano, Roberto Sanchez de Leo ´n* Unidad de Fisiologia Respiratoria, Instituto de Medicina Experimental, Facultad de Medicina, Escuela Luis Razetti, Uniersidad Central de Venezuela, Caracas, Venezuela Accepted 24 August 1998 Abstract We have studied the effects of fenoterol on PAF-induced response in pulmonary circulation. We used 28 isolated and perfused rabbit lungs preparations: eight control preparations (CP), four vehicles preparations (VP), eight PAF preparations (PP) with two doses of PAF, one called low dose (LD =0.5 g/kg of weight) and the other high dose (HD =1 g/kg of weight) and eight Fenoterol preparations (FP) which we administered 0.05 mg of Fenoterol for 15 min, followed by a LD and HD of PAF. FP prevented elevation of pulmonary artery pressure (Ppa) as compared to PP, at LD of PAF: 12.615 (CI 95%: 8.57–20.885) versus 83.705 (CI 95%: 50.55–114.3) cm of water; and at HD of PAF: 19.38 (CI 95%: 11.235–28.94) versus 205.1 (CI 95%: 141.3–271) cm of water respectively. FP prevented the increase in fluid filtration rate (FFR) observed in PP at both doses of PAF LD: 0.765 (CI 95%: 0.07–3.385) versus -0.01 (CI 95%: -0.05–0.005) g/min; HD: 5.515 (CI 95%: 2.425–8.865) versus 0.03 (CI 95%: 0–0.33) g/min. Our results suggest that PAF has a vasoconstrictor effect that produces lung edema and this effect is inhibited by fenoterol. © 1998 Published by Elsevier Science B.V. All rights reserved. Keywords: Disease; Acute Respiratory Distress Syndrome; Lung edema; Hypertension; Pulmonary; Mammals; Rabbit; Mediators; Platelet activating factor; Pharmacological agents; Pulmonary blood flow; Fenoterol 1. Introduction Platelet Activating Factor (PAF) has been defined as a group of choline-containing phospho- lipids that stimulate platelets (Mc Manus et al., 1993). PAF is synthesized by the majority of inflammatory cells and by the endothelium, being * Corresponding author. Present address: POBA Interna- tional 281, PO Box 025255, Miami, FL 33102, USA. Tel.: +1-582-5086302; fax: +1-582-7316856; e-mail: rsanchez@ven.net www.rsdl.com. 0034-5687/98/$ - see front matter © 1998 Published by Elsevier Science B.V. All rights reserved. PII:S0034-5687(98)00082-6